Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

NCT05249374 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Ascites

Interventions

DRUG: Recombinant Human Serum Albumin
DRUG: Human serum albumin

Sponsor

Protgen Ltd